Microbiota diversity and its influence on diabetic osteoporosis development

Area of Science:

• Endocrinology and Metabolism
• Microbiology
• Bone Biology

Background:

• Diabetic osteoporosis, a complication of diabetes, involves impaired bone quality and elevated fracture risk, often linked to chronic hyperglycemia.
• Gut microbiota dysbiosis and osteoporotic changes are observed in type II diabetes mellitus (T2DM) rat models, but the underlying mechanisms are unclear.

Purpose of the Study:

• To elucidate the mechanisms by which gut microbiota contributes to diabetic osteoporosis.
• To analyze microbiome profiling and pathway enrichment in a T2DM rat model.

Main Methods:

• Established a male T2DM rat model using a high-fat diet (HFD) and streptozotocin (STZ).
• Assessed bone structural integrity via micro-computed tomography.
• Analyzed gut microbiota composition using 16S rRNA gene pyrosequencing and bioinformatic processing.

Main Results:

• T2DM rats showed elevated proinflammatory cytokines, negatively correlated with bone density and turnover markers.
• Decreased beneficial bacteria (e.g., Lactobacillus) and increased pathogenic bacteria (e.g., Enterococcus) were observed.
• Impaired short-chain fatty acid (SCFA) metabolism and enhanced tryptophan metabolism were linked to reduced bone mass.

Conclusions:

• Microbiota-driven alterations in SCFA production contribute to systemic inflammation and bone loss in T2DM.
• Identifying key microbial metabolites and pathways may enable microbiome-targeted therapies for metabolic and skeletal health in diabetic populations.